Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Go back to Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 329.93 +6.18 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.75 | 52 Week High | $141.32 | |||
| Open | $320.20 | 52 Week Low | $97.79 | |||
| Day High | $331.71 | P/E | 52.79 | |||
| Day Low | $314.78 | EPS | $6.25 | |||
| Volume | 961,892 | |||||



